In vitro basophil activation is reduced by short-term omalizumab treatment in hydrolyzed wheat protein allergy

Allergol Int. 2020 Apr;69(2):284-286. doi: 10.1016/j.alit.2019.09.006. Epub 2019 Nov 18.

¹ Department of Dermatology, Shimane University Faculty of Medicine, Shimane, Japan. Electronic address: ychinuki@med.shimane-u.ac.jp.
² Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan.
³ Department of Dermatology, Hyogo Prefectural Kakogawa Medical Center, Hyogo, Japan.
⁴ Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan.
⁵ Department of Dermatology, Tokyo Medical and Dental University, Tokyo, Japan.
⁶ Department of Dermatology, Osaka General Medical Center, Osaka, Japan.
⁷ Department of Pigmentation Research and Therapeutics, Osaka City University, Osaka, Japan.
⁸ Department of Dermatology, Shimane University Faculty of Medicine, Shimane, Japan; Center for Community-Based Health Research and Education (COHRE), Organization for Research and Academic Information, Shimane University, Shimane, Japan.
⁹ Shimane University Faculty of Medicine, Shimane, Japan.
¹⁰ Department of Dermatology, Shimane University Faculty of Medicine, Shimane, Japan.

No abstract available

Publication types